首页> 外文期刊>High-Throughput >Precision Medicine in Non-Communicable Diseases
【24h】

Precision Medicine in Non-Communicable Diseases

机译:非传染病的精密药物

获取原文
       

摘要

The increase in life expectancy during the 20th century ranks as one of society’s greatest achievements, with massive growth in the numbers and proportion of the elderly, virtually occurring in every country of the world. The burden of chronic diseases is one of the main consequences of this phenomenon, severely hampering the quality of life of elderly people and challenging the efficiency and sustainability of healthcare systems. Non-communicable diseases (NCDs) are considered a global emergency responsible for over 70% of deaths worldwide. NCDs are also the basis for complex and multifactorial diseases such as hypertension, diabetes, and obesity. The epidemics of NCDs are a consequence of a complex interaction between health, economic growth, and development. This interaction includes the individual genome, the microbiome, the metabolome, the immune status, and environmental factors such as nutritional and chemical exposure. To counteract NCDs, it is therefore essential to develop an innovative, personalized, preventative, early care model through the integration of different molecular profiles of individuals to identify both the critical biomarkers of NCD susceptibility and to discover novel therapeutic targets.
机译:20世纪20世纪的预期寿命的增加是社会最大成就之一,具有大量增长的老年人的数量和比例,在世界各国几乎发生。慢性病的负担是这种现象的主要后果之一,严重阻碍了老年人的生活质量,并挑战了医疗保健系统的效率和可持续性。非传染性疾病(NCD)被认为是全球60%以上的全球紧急情况。 NCD也是复杂和多重疾病,如高血压,糖尿病和肥胖症的基础。 NCD的流行病是健康,经济增长和发展之间复杂的互动的结果。该相互作用包括个体基因组,微生物组,代谢物,免疫状态和环境因素,如营养和化学暴露。为了抵消NCD,因此必须通过整合个体的不同分子曲线来制定创新,个性化,预防性,早期护理模型,以确定NCD易感性的关键生物标志物,并探索新的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号